BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36205544)

  • 1. Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways.
    Li W; Mao Y; Hua B; Gu X; Lu C; Xu B; Pan W
    Pharm Biol; 2022 Dec; 60(1):1865-1875. PubMed ID: 36205544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure Identification of ViceninII Extracted from
    Luo Y; Ren Z; Du B; Xing S; Huang S; Li Y; Lei Z; Li D; Chen H; Huang Y; Wei G
    Molecules; 2019 Jan; 24(1):. PubMed ID: 30609689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoviolanthin Extracted from
    Xing S; Yu W; Zhang X; Luo Y; Lei Z; Huang D; Lin J; Huang Y; Huang S; Nong F; Zhou C; Wei G
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29882900
    [No Abstract]   [Full Text] [Related]  

  • 4. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway.
    Zhang G; Li Z; Dong J; Zhou W; Zhang Z; Que Z; Zhu X; Xu Y; Cao N; Zhao A
    BMC Complement Med Ther; 2022 Jan; 22(1):10. PubMed ID: 35000605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
    Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway.
    Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ
    J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.
    Yang MH; Jung SH; Um JY; Kumar AP; Sethi G; Ahn KS
    Life Sci; 2022 Apr; 295():120395. PubMed ID: 35181309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation.
    Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
    J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
    Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total flavonoids from Smilax glabra Roxb blocks epithelial-mesenchymal transition and inhibits renal interstitial fibrosis by targeting miR-21/PTEN signaling.
    Luo Q; Cai Z; Tu J; Ling Y; Wang D; Cai Y
    J Cell Biochem; 2019 Mar; 120(3):3861-3873. PubMed ID: 30304552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
    Dong F; Liu T; Jin H; Wang W
    Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual PI3K/mTOR inhibitor NVP-BEZ235 prevents epithelial-mesenchymal transition induced by hypoxia and TGF-β1.
    Lin G; Gai R; Chen Z; Wang Y; Liao S; Dong R; Zhu H; Gu Y; He Q; Yang B
    Eur J Pharmacol; 2014 Apr; 729():45-53. PubMed ID: 24561043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.
    Zhu J; Wen K
    Phytother Res; 2018 Jul; 32(7):1289-1296. PubMed ID: 29480652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.
    Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
    Cell Death Dis; 2013 Oct; 4(10):e875. PubMed ID: 24157869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stachydrine inhibits TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells through the TGF-β/Smad and PI3K/Akt/mTOR signaling pathways.
    Chen X; Yan N
    Anticancer Drugs; 2021 Sep; 32(8):786-792. PubMed ID: 33675608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/Smad2 Signaling in Prostate Cancer.
    Qin X; Liu L; Li Y; Luo H; Chen H; Weng X
    Technol Cancer Res Treat; 2023; 22():15330338231153618. PubMed ID: 36999196
    [No Abstract]   [Full Text] [Related]  

  • 19. Sasanquasaponin ΙΙΙ from Schima crenata Korth induces autophagy through Akt/mTOR/p70S6K pathway and promotes apoptosis in human melanoma A375 cells.
    Liang QP; Xu TQ; Liu BL; Lei XP; Hambrook JR; Zhang DM; Zhou GX
    Phytomedicine; 2019 May; 58():152769. PubMed ID: 31005714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway.
    Wu HE; Su CC; Wang SC; Liu PL; Cheng WC; Yeh HC; Chuu CP; Chen JK; Bao BY; Lee CH; Ke CC; Chen YR; Yu YH; Huang SP; Li CY
    Am J Chin Med; 2023; 51(4):1019-1039. PubMed ID: 37120705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.